, Changes in causes of death among adults infected by HIV between, 2000.
URL : https://hal.archives-ouvertes.fr/inserm-00337877
, J. Acquir. Immune Defic. Syndr, vol.48, pp.590-598
Pattern of cancer risk in persons with AIDS in Italy in the HAART era, Cancer and AIDS Registries Linkage, vol.100, pp.840-847, 2009. ,
Stem cell transplantation for lymphoma patients with HIV infection, Cell Transplant, vol.20, pp.351-370, 2011. ,
Outcomes of autologous stem cell transplantation (ASCT) in patients with relapsed/refractory HIV-associated lymphoma, Bone Marrow Transplant, vol.51, pp.1609-1611, 2016. ,
Autologous hematopoietic cell transplantation for HIV, 2016. ,
, Trial. Blood, vol.128, pp.1050-1058
Immune recovery after autologous stem cell transplantation is not different for HIV-infected versus HIV-uninfected patients with relapsed or refractory lymphoma, Clin. Infect. Dis, vol.50, pp.1672-1679, 2010. ,
RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphoma, Sci. Transl. Med, vol.2, pp.36-43, 2010. ,
Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation, N. Engl. J. Med, vol.360, pp.692-698, 2009. ,
Evidence for the cure of HIV infection by CCR5D32/D32 stem cell transplantation, Blood, vol.117, pp.2791-2799, 2011. ,
CCR5D32 mutation and HIV infection: basis for curative HIV therapy, Curr Opin Virol, vol.14, pp.24-29, 2015. ,
Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases, Nat. Biotechnol, vol.26, pp.808-816, 2008. ,
Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV, N. Engl. J. Med, vol.370, pp.901-910, 2014. ,
Inhibition of human immunodeficiency virus type 1 entry in cells expressing gp41-derived peptides, J. Virol, vol.78, pp.568-575, 2004. ,
Efficient entry inhibition of human and nonhuman primate immunodeficiency virus by cell surface-expressed gp41-derived peptides, Gene Ther, vol.15, pp.1210-1222, 2008. ,
Transfer of autologous gene-modified T cells in HIV-infected patients with advanced immunodeficiency and drug-resistant virus, Mol. Ther, vol.15, pp.1024-1033, 2007. ,
Preclinical safety and efficacy of an anti-HIV-1 lentiviral vector containing a short hairpin RNA to CCR5 and the C46 fusion inhibitor, Mol. Ther. Methods Clin. Dev, vol.1, p.11, 2014. ,
Engineering Cellular Resistance to HIV-1 Infection In Vivo Using a Dual Therapeutic Lentiviral Vector, Mol. Ther. Nucleic Acids, vol.4, p.236, 2015. ,
Analysis and dissociation of anti-HIV effects of shRNA to CCR5 and the fusion inhibitor C46, J. Gene Med, vol.20, p.3006, 2018. ,